Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses TWST in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named TWST in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Emily Leproust | $720,000 | $0 | $11,998,134 | $0 | $932,918 | $0 | $130,518 | $13,781,570 |
| Chief Executive Officer and Chair of the Board | ||||||||
| Patrick Finn | 563,000 | 0 | 6,748,947 | 0 | 583,592 | 0 | 127,403 | 8,022,942 |
| President and Chief Operating Officer | ||||||||
| Adam Laponis | 490,000 | 0 | 3,365,430 | 0 | 349,197 | 0 | 11,490 | 4,216,117 |
| Chief Financial Officer | ||||||||
| Dennis Cho | 449,000 | 0 | 2,872,062 | 0 | 290,889 | 0 | 9,125 | 3,621,076 |
| Chief Legal Officer and Corporate Secretary | ||||||||
| Paula Green | 400,000 | 0 | 2,570,537 | 0 | 259,144 | 0 | 119,178 | 3,348,859 |
| Senior Vice President of Human Resources | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Emily Leproust | $13,781,570 | $7,620,611 | $7,998,637 | +6,160,959 |
| Patrick Finn | 8,022,942 | 3,854,551 | 5,227,858 | +4,168,391 |
| Adam Laponis | 4,216,117 | 5,008,244 | — | −792,127 |
| Dennis Cho | 3,621,076 | 1,798,432 | 1,647,954 | +1,822,644 |
| Paula Green | 3,348,859 | 2,005,681 | 2,487,420 | +1,343,178 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Adam Laponis | Chief Financial Officer | 2026-01-09 | D | 2,738 | $35 | $96,545 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-01-13 | D | 3,000 | 40 | 120,000 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-01-13 | A | 3,279 | 9 | 28,921 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-01-13 | D | 3,279 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-01-13 | D | 23,279 | 40 | 931,160 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-01-23 | D | 2,390 | 45 | 107,330 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-02-03 | D | 5,001 | 47 | 232,927 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-02-03 | D | 1,099 | 47 | 51,187 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-02-03 | D | 7,000 | 46 | 319,536 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-03 | D | 2,705 | 47 | 125,988 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-02-03 | D | 175 | 47 | 8,151 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-02-03 | D | 1,194 | 47 | 55,612 | Common | Form 4 ↗ |
| Jan Johannessen | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Keith Crandell | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Jan Johannessen | Director | 2026-02-05 | D | 2,200 | 48 | 105,395 | Common | Form 4 ↗ |
| Nelson C. Chan | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Trynka Shineman Blake | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Robert Chess | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Robert Ragusa | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Melissa A. Starovasnik | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-02-09 | D | 2,000 | 0 | 0 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-02-11 | D | 5,000 | 50 | 249,650 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-02-12 | — | 3,712 | — | — | 1 insider, 4 accrual rows | ||
| Patrick Finn | President and COO | 2026-02-12 | D | 3,500 | 50 | 175,788 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | A | 712 | 27 | 18,982 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | A | 1,500 | 27 | 39,990 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | A | 1,000 | 23 | 23,330 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-02-12 | D | 7,000 | 50 | 350,000 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | D | 1,750 | 50 | 87,572 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | A | 500 | 23 | 11,665 | Common | Form 4 ↗ |
| Robert Chess | Director | 2026-02-13 | D | 2,184 | 48 | 105,402 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 3,541 | 53 | 188,063 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 21,858 | 50 | 1,099,916 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | A | 32,300 | 27 | 861,118 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 32,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 16,616 | 51 | 854,445 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 26,952 | 53 | 1,419,993 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 18,205 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | A | 18,205 | 23 | 424,723 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-02-17 | D | 39,404 | 52 | 2,064,770 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-02-23 | D | 844 | 47 | 39,423 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-02-23 | D | 1,465 | 47 | 68,430 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-02-23 | D | 1,693 | 47 | 79,080 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-02-23 | D | 7,205 | 47 | 336,544 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-23 | D | 4,294 | 47 | 200,572 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-02-23 | D | 2,085 | 47 | 97,390 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-03-06 | D | 246 | 46 | 11,421 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-03-06 | D | 935 | 46 | 43,408 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-03-06 | D | 425 | 46 | 19,731 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-03-06 | D | 2,423 | 46 | 112,490 | Common | Form 4 ↗ |
| Robert Chess | Director | 2026-03-17 | D | 10,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Robert Chess | Director | 2026-03-17 | D | 10,000 | 47 | 470,000 | Common | Form 4 ↗ |
| Robert Chess | Director | 2026-03-17 | A | 10,000 | 12 | 118,900 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-03-20 | D | 297 | 44 | 13,005 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-03-20 | D | 1,742 | 44 | 76,276 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-03-20 | D | 354 | 44 | 15,500 | Common | Form 4 ↗ |
| Melissa A. Starovasnik | Director | 2026-04-01 | D | 1,000 | 51 | 51,000 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-04-09 | D | 2,597 | 50 | 129,562 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-04-14 | D | 3,000 | 55 | 165,000 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-04-17 | D | 4,000 | 60 | 240,000 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | D | 151 | 66 | 9,966 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | A | 1,610 | 9 | 14,200 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | A | 8,061 | 9 | 71,098 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | A | 8,061 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-04-21 | — | 1,610 | — | — | 1 insider, 1 accrual row | ||
| Emily M. Leproust | Director | 2026-04-21 | D | 1,610 | 65 | 104,666 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | D | 7,910 | 65 | 516,325 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-04-23 | D | 2,321 | 61 | 141,026 | Common | Form 4 ↗ |
| Melissa A. Starovasnik | Director | 2026-04-27 | D | 500 | 62 | 30,915 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-05-04 | D | 1,116 | 57 | 63,778 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-04 | D | 5,127 | 57 | 293,002 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-05-04 | D | 1,962 | 57 | 112,126 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-05-04 | D | 164 | 57 | 9,372 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-05-04 | D | 2,844 | 57 | 162,531 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-05-08 | D | 4,961 | 57 | 282,187 | Common | Form 4 ↗ |
| Jan Johannessen | Director | 2026-05-12 | A | 12,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jan Johannessen | Director | 2026-05-12 | D | 12,000 | 56 | 673,440 | Common | Form 4 ↗ |
| Jan Johannessen | Director | 2026-05-12 | A | 12,000 | 14 | 168,000 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-05-21 | D | 1,642 | 53 | 87,448 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-05-21 | D | 1,399 | 53 | 74,507 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-05-21 | D | 4,160 | 53 | 221,549 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-05-21 | D | 2,019 | 53 | 107,526 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-21 | D | 6,888 | 53 | 366,834 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-05-21 | D | 688 | 53 | 36,641 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | A | 25,017 | 9 | 220,650 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | D | 23,752 | 65 | 1,549,561 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-05-26 | D | 800 | 62 | 49,987 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | D | 1,265 | 66 | 83,846 | Common | Form 4 ↗ |
| Melissa A. Starovasnik | Director | 2026-05-26 | D | 500 | 61 | 30,520 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | A | 24,282 | 9 | 214,167 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | A | 24,282 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | D | 24,282 | 65 | 1,580,246 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | A | 25,017 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | D | 16,470 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | A | 16,470 | 9 | 145,265 | Common | Form 4 ↗ |
| Melissa A. Starovasnik | Director | 2026-05-28 | D | 2,500 | 68 | 170,000 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | D | 7,623 | 68 | 517,989 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | D | 900 | 67 | 60,163 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | D | 1,482 | 65 | 96,813 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | D | 6,465 | 69 | 443,590 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-05-29 | D | 14,205 | 70 | 990,799 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-05-29 | D | 4,000 | 70 | 280,000 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-06-08 | D | 232 | 70 | 16,204 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-06-08 | D | 2,265 | 70 | 158,197 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-06-08 | D | 402 | 70 | 28,077 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-06-08 | D | 1,127 | 69 | 77,842 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-06-08 | D | 500 | 0 | 0 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-08 | D | 884 | 70 | 61,742 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-15 | A | 26,137 | 23 | 609,776 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-15 | D | 2,028 | 82 | 166,632 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-15 | D | 24,109 | 82 | 1,967,856 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-15 | D | 26,137 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-06-22 | D | 1,688 | 87 | 147,400 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-22 | D | 291 | 87 | 25,411 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-06-22 | D | 346 | 87 | 30,214 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-06-24 | D | 14,205 | 90 | 1,274,899 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-06-25 | D | 18,880 | 95 | 1,793,600 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-07-09 | D | 2,399 | 94 | 226,307 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-07-23 | D | 2,238 | 94 | 210,133 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Adam Laponis | Chief Financial Officer | 2026-01-09 | D | 2,738 | $35 | $96,545 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-01-13 | D | 3,000 | 40 | 120,000 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-01-13 | A | 3,279 | 9 | 28,921 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-01-13 | D | 3,279 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-01-13 | D | 23,279 | 40 | 931,160 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-01-23 | D | 2,390 | 45 | 107,330 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-02-03 | D | 5,001 | 47 | 232,927 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-02-03 | D | 1,099 | 47 | 51,187 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-02-03 | D | 7,000 | 46 | 319,536 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-03 | D | 2,705 | 47 | 125,988 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-02-03 | D | 175 | 47 | 8,151 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-02-03 | D | 1,194 | 47 | 55,612 | Common | Form 4 ↗ |
| Jan Johannessen | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Keith Crandell | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Jan Johannessen | Director | 2026-02-05 | D | 2,200 | 48 | 105,395 | Common | Form 4 ↗ |
| Nelson C. Chan | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Trynka Shineman Blake | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Robert Chess | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Robert Ragusa | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Melissa A. Starovasnik | Director | 2026-02-05 | A | 5,095 | 0 | 0 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-02-09 | D | 2,000 | 0 | 0 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-02-11 | D | 5,000 | 50 | 249,650 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | D | 712 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | D | 3,500 | 50 | 175,788 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | A | 712 | 27 | 18,982 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | D | 500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | A | 1,500 | 27 | 39,990 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | A | 1,000 | 23 | 23,330 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-02-12 | D | 7,000 | 50 | 350,000 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | D | 1,750 | 50 | 87,572 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | A | 500 | 23 | 11,665 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | D | 1,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-12 | D | 1,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Robert Chess | Director | 2026-02-13 | D | 2,184 | 48 | 105,402 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 3,541 | 53 | 188,063 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 21,858 | 50 | 1,099,916 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | A | 32,300 | 27 | 861,118 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 32,300 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 16,616 | 51 | 854,445 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 26,952 | 53 | 1,419,993 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | D | 18,205 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-17 | A | 18,205 | 23 | 424,723 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-02-17 | D | 39,404 | 52 | 2,064,770 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-02-23 | D | 844 | 47 | 39,423 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-02-23 | D | 1,465 | 47 | 68,430 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-02-23 | D | 1,693 | 47 | 79,080 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-02-23 | D | 7,205 | 47 | 336,544 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-02-23 | D | 4,294 | 47 | 200,572 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-02-23 | D | 2,085 | 47 | 97,390 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-03-06 | D | 246 | 46 | 11,421 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-03-06 | D | 935 | 46 | 43,408 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-03-06 | D | 425 | 46 | 19,731 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-03-06 | D | 2,423 | 46 | 112,490 | Common | Form 4 ↗ |
| Robert Chess | Director | 2026-03-17 | D | 10,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Robert Chess | Director | 2026-03-17 | D | 10,000 | 47 | 470,000 | Common | Form 4 ↗ |
| Robert Chess | Director | 2026-03-17 | A | 10,000 | 12 | 118,900 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-03-20 | D | 297 | 44 | 13,005 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-03-20 | D | 1,742 | 44 | 76,276 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-03-20 | D | 354 | 44 | 15,500 | Common | Form 4 ↗ |
| Melissa A. Starovasnik | Director | 2026-04-01 | D | 1,000 | 51 | 51,000 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-04-09 | D | 2,597 | 50 | 129,562 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-04-14 | D | 3,000 | 55 | 165,000 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-04-17 | D | 4,000 | 60 | 240,000 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | D | 151 | 66 | 9,966 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | A | 1,610 | 9 | 14,200 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | A | 8,061 | 9 | 71,098 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | A | 8,061 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | A | 1,610 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | D | 1,610 | 65 | 104,666 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-04-21 | D | 7,910 | 65 | 516,325 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-04-23 | D | 2,321 | 61 | 141,026 | Common | Form 4 ↗ |
| Melissa A. Starovasnik | Director | 2026-04-27 | D | 500 | 62 | 30,915 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-05-04 | D | 1,116 | 57 | 63,778 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-04 | D | 5,127 | 57 | 293,002 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-05-04 | D | 1,962 | 57 | 112,126 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-05-04 | D | 164 | 57 | 9,372 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-05-04 | D | 2,844 | 57 | 162,531 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-05-08 | D | 4,961 | 57 | 282,187 | Common | Form 4 ↗ |
| Jan Johannessen | Director | 2026-05-12 | A | 12,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jan Johannessen | Director | 2026-05-12 | D | 12,000 | 56 | 673,440 | Common | Form 4 ↗ |
| Jan Johannessen | Director | 2026-05-12 | A | 12,000 | 14 | 168,000 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-05-21 | D | 1,642 | 53 | 87,448 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-05-21 | D | 1,399 | 53 | 74,507 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-05-21 | D | 4,160 | 53 | 221,549 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-05-21 | D | 2,019 | 53 | 107,526 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-21 | D | 6,888 | 53 | 366,834 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-05-21 | D | 688 | 53 | 36,641 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | A | 25,017 | 9 | 220,650 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | D | 23,752 | 65 | 1,549,561 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-05-26 | D | 800 | 62 | 49,987 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | D | 1,265 | 66 | 83,846 | Common | Form 4 ↗ |
| Melissa A. Starovasnik | Director | 2026-05-26 | D | 500 | 61 | 30,520 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | A | 24,282 | 9 | 214,167 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | A | 24,282 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | D | 24,282 | 65 | 1,580,246 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-26 | A | 25,017 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | D | 16,470 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | A | 16,470 | 9 | 145,265 | Common | Form 4 ↗ |
| Melissa A. Starovasnik | Director | 2026-05-28 | D | 2,500 | 68 | 170,000 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | D | 7,623 | 68 | 517,989 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | D | 900 | 67 | 60,163 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | D | 1,482 | 65 | 96,813 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-05-28 | D | 6,465 | 69 | 443,590 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-05-29 | D | 14,205 | 70 | 990,799 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-05-29 | D | 4,000 | 70 | 280,000 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-06-08 | D | 232 | 70 | 16,204 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-06-08 | D | 2,265 | 70 | 158,197 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-06-08 | D | 402 | 70 | 28,077 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-06-08 | D | 1,127 | 69 | 77,842 | Common | Form 4 ↗ |
| Robert F. Werner | Chief Accounting Officer | 2026-06-08 | D | 500 | 0 | 0 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-08 | D | 884 | 70 | 61,742 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-15 | A | 26,137 | 23 | 609,776 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-15 | D | 2,028 | 82 | 166,632 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-15 | D | 24,109 | 82 | 1,967,856 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-15 | D | 26,137 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-06-22 | D | 1,688 | 87 | 147,400 | Common | Form 4 ↗ |
| Paula Green | SVP of Human Resources | 2026-06-22 | D | 291 | 87 | 25,411 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-06-22 | D | 346 | 87 | 30,214 | Common | Form 4 ↗ |
| Dennis Cho | See Remarks | 2026-06-24 | D | 14,205 | 90 | 1,274,899 | Common | Form 4 ↗ |
| Emily M. Leproust | Director | 2026-06-25 | D | 18,880 | 95 | 1,793,600 | Common | Form 4 ↗ |
| Adam Laponis | Chief Financial Officer | 2026-07-09 | D | 2,399 | 94 | 226,307 | Common | Form 4 ↗ |
| Patrick Finn | President and COO | 2026-07-23 | D | 2,238 | 94 | 210,133 | Common | Form 4 ↗ |
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Adam Laponis | PSU | 2024-12-04 | 13,373 | 26,746 | — | 37,444 | $1,963,190 |
| Adam Laponis | RSU | 2024-12-04 | — | — | 13,373 | — | 26,746 |
| Patrick Finn | RSU | 2024-12-04 | — | — | 26,818 | — | 53,635 |
| Emily Leproust | RSU | 2024-12-04 | — | — | 95,350 | — | 4,999,201 |
| Emily Leproust | RSU | 2024-12-04 | — | — | 47,676 | — | 95,351 |
| Paula Green | RSU | 2024-12-04 | — | — | 20,428 | — | 1,071,040 |
| Patrick Finn | RSU | 2024-12-04 | — | — | 53,634 | — | 2,812,031 |
| Emily Leproust | PSU | 2024-12-04 | 47,676 | 95,351 | — | 133,491 | 6,998,933 |
| Paula Green | PSU | 2024-12-04 | 10,215 | 20,429 | — | 28,600 | 1,499,497 |
| Dennis Cho | RSU | 2024-12-04 | — | — | 11,413 | — | 22,825 |
| Adam Laponis | RSU | 2024-12-04 | — | — | 26,745 | — | 1,402,240 |
| Dennis Cho | PSU | 2024-12-04 | 11,413 | 22,825 | — | 31,955 | 1,675,400 |
| Patrick Finn | PSU | 2024-12-04 | 26,818 | 53,635 | — | 75,089 | 3,936,916 |
| Paula Green | RSU | 2024-12-04 | — | — | 10,215 | — | 20,429 |
| Dennis Cho | RSU | 2024-12-04 | — | — | 22,824 | — | 1,196,662 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Adam Laponis | $1,428,986 | $1,963,190 | $0 | 57.9% |
| Patrick Finn | 2,865,666 | 3,936,916 | 0 | 57.9% |
| Emily Leproust | 5,094,552 | 6,998,933 | 0 | 57.9% |
| Paula Green | 1,091,469 | 1,499,497 | 0 | 57.9% |
| Dennis Cho | 1,219,487 | 1,675,400 | 0 | 57.9% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Emily Leproust | PSU | 77,473 | — | $2,180,090 |
| Emily Leproust | PSU | 40,431 | — | 1,137,728 |
| Adam Laponis | PSU | 37,444 | — | 1,053,674 |
| Adam Laponis | PSU | 21,732 | — | 611,538 |
| Patrick Finn | PSU | 9,572 | — | 269,356 |
| Paula Green | PSU | 16,600 | — | 467,124 |
| Patrick Finn | PSU | 379 | — | 10,665 |
| Paula Green | Option | 0 | 26.66 | — |
| Paula Green | Option | 0 | 23.33 | — |
| Emily Leproust | Option | 0 | 26.66 | — |
| Paula Green | Option | 0 | 67.85 | — |
| Emily Leproust | Option | 0 | 23.33 | — |
| Emily Leproust | Option | 0 | 8.82 | — |
| Emily Leproust | PSU | 48,513 | — | 1,365,156 |
| Emily Leproust | PSU | 133,491 | — | 3,756,437 |
| Patrick Finn | PSU | 44,883 | — | 1,263,008 |
| Paula Green | PSU | 35,513 | — | 999,336 |
| Patrick Finn | PSU | 11,090 | — | 312,073 |
| Dennis Cho | PSU | 4,710 | — | 132,539 |
| Dennis Cho | PSU | 342 | — | 9,624 |
| Dennis Cho | PSU | 31,955 | — | 899,214 |
| Emily Leproust | PSU | 27,573 | — | 775,904 |
| Paula Green | PSU | 19,980 | — | 562,237 |
| Dennis Cho | PSU | 6,000 | — | 168,840 |
| Dennis Cho | Option | 8,194 | 115.93 | — |
| Paula Green | PSU | 290 | — | 8,161 |
| Patrick Finn | Option | 0 | 26.66 | — |
| Paula Green | Option | 0 | 8.82 | — |
| Emily Leproust | PSU | 168,976 | — | 4,754,985 |
| Paula Green | PSU | 3,045 | — | 85,686 |
| Dennis Cho | PSU | 16,605 | — | 467,265 |
| Dennis Cho | PSU | 3,192 | — | 89,823 |
| Patrick Finn | Option | 0 | 8.82 | — |
| Emily Leproust | Option | 0 | 67.85 | — |
| Patrick Finn | Option | 0 | 67.85 | — |
| Patrick Finn | PSU | 18,000 | — | 506,520 |
| Patrick Finn | Option | 0 | 23.33 | — |
| Paula Green | PSU | 15,000 | — | 422,100 |
| Paula Green | PSU | 18,000 | — | 506,520 |
| Adam Laponis | PSU | 46,878 | — | 1,319,147 |
| Adam Laponis | PSU | 37,000 | — | 1,041,180 |
| Dennis Cho | PSU | 29,518 | — | 830,637 |
| Paula Green | PSU | 28,600 | — | 804,804 |
| Emily Leproust | PSU | 18,675 | — | 525,515 |
| Dennis Cho | PSU | 18,546 | — | 521,884 |
| Patrick Finn | PSU | 16,373 | — | 460,736 |
| Patrick Finn | PSU | 14,131 | — | 397,646 |
| Dennis Cho | PSU | 7,200 | — | 202,608 |
| Paula Green | PSU | 4,491 | — | 126,377 |
| Emily Leproust | PSU | 1,053 | — | 29,631 |
| Emily Leproust | PSU | 95,049 | — | 2,674,679 |
Provide a significant portion of compensation through variable, performance-based components that are at-risk and based on satisfaction of designated financial and non-financial objectives
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-02-06 | 38,430,673 | 11,842,367 | 32,663 | 76.44% | Passed |
| 2025 | 2025-02-05 | 49,586,486 | 1,201,241 | 30,571 | 97.63% | Passed |
| 2024 | 2024-02-06 | 43,215,571 | 2,904,714 | 31,874 | 93.7% | Passed |
| 2023 | 2023-02-07 | 43,379,295 | 3,746,996 | 30,003 | 92.05% | Passed |
| 2022 | 2022-02-08 | 36,736,935 | 5,872,414 | 29,145 | 86.22% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-02-06 | 76.44%a |
| 2025 | 2025-02-05 | 97.63%b |
| 2024 | 2024-02-06 | 93.7%c |
a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect and will not be counted towards the vote totals for proposals 2 and 3.”.
b. Approved under the standard stated in the filing — “If you abstain from voting on Proposal 2, the abstention will have no effect on the outcome of the non-binding, advisory vote to approve the compensation of the Company's named executive officers, as disclosed in this proxy statement.”.
c. Approved under the standard stated in the filing — “If you ABSTAIN from voting on proposal 2, the abstention will have no effect on the outcome of the non-binding, advisory vote to approve the compensation of the Company's named executive officers, as disclosed in this proxy statement.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 73.2 : 1 |
|---|---|
| CEO total compensation | $13,781,570 |
| Median employee compensation | $188,208 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Trynka Shineman BlakeIndependent · Audit and Risk · Newly elected | $9,000 | $394,995 | $0 | $0 | — | $403,995 |
| Robert ChessIndependent · Lead Independent Director · Compensation · Nominating and Corporate Governance (Chair) | 97,500 | 239,968 | 0 | 0 | — | 337,468 |
| Jan JohannessenIndependent · Audit and Risk (Chair) · Nominating and Corporate Governance | 73,750 | 239,968 | 0 | 0 | — | 313,718 |
| Nelson C. ChanIndependent · Audit and Risk · Nominating and Corporate Governance | 72,500 | 239,968 | 0 | 0 | — | 312,468 |
| Melissa A. StarovasnikIndependent · Compensation (Chair) | 65,000 | 239,968 | 0 | 0 | — | 304,968 |
| Robert RagusaIndependent · Audit and Risk · Compensation | 65,000 | 239,968 | 0 | 0 | — | 304,968 |
| Keith CrandellIndependent · Compensation · Nominating and Corporate Governance | 60,000 | 239,968 | 0 | 0 | — | 299,968 |
| Xiaoying MaiIndependent · Departed during FY | 33,393 | — | 0 | 0 | 148,559 | 181,952 |
| Emily M. LeproustEmployee director · Board Chair · Compensation (Chair) | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $50,000 |
|---|---|
| Annual equity retainer | $239,968 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 22,500 / 17,500 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $476,143 |
| Equity awards (grant-date value) | $1,834,803 |
| All other compensation | $148,559 |
| Total cost of the board | $2,459,505 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Twist Bioscience Corp names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Twist Bioscience Corp.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Natera, Inc. | 2025 | Steven Chapman | $853,710 | $12,979,558 | $0 | $1,114,151 | $14,957,319 |
| 2 | Insmed Incorporated | 2025 | William Lewis | 854,550 | 2,999,940 | 9,000,033 | 1,495,463 | 14,467,393 |
| 3 | Twist Bioscience Corp | 2025 | Emily Leproust | 720,000 | 11,998,134 | 0 | 932,918 | 13,781,570 |
| 4 | NovoCure Limited | 2025 | Ashley Cordova | 901,837 | 8,249,965 | 2,752,814 | 811,653 | 13,198,354 |
| 5 | Ultragenyx Pharmaceutical Inc. | 2025 | Emil Kakkis | 861,100 | 8,364,938 | 1,847,356 | 299,663 | 11,405,535 |
| 6 | Azenta, Inc. | 2025 | John Marotta | 900,000 | 8,386,297 | 0 | 1,063,656 | 10,371,414 |
| 7 | Maravai LifeSciences Holdings, Inc. | 2025 | Bernd Brust | 388,863 | 7,660,000 | 1,460,000 | 425,343 | 10,129,708 |
| 8 | NeoGenomics, Inc. | 2025 | Tony Zook | 601,539 | 3,999,997 | 3,998,235 | 513,400 | 9,127,092 |
| 9 | Guardant Health, Inc. | 2025 | AmirAli Talasaz | 1 | 8,647,709 | 0 | 0 | 8,661,227 |
| 10 | Veracyte, Inc. | 2025 | Marc Stapley | 700,000 | 5,890,877 | 0 | 826,000 | 7,421,877 |
| 11 | CareDx, Inc. | 2025 | John Hanna | 693,269 | 5,622,638 | 0 | 852,515 | 7,179,699 |
| 12 | BioLife Solutions, Inc. | 2024 | Roderick de Greef | 744,450 | 5,571,874 | 0 | 655,116 | 7,046,205 |
| 13 | 10x Genomics, Inc. | 2025 | Serge Saxonov | 674,250 | 5,020,269 | 0 | 634,725 | 6,329,244 |
| 14 | Quanterix Corporation | 2025 | Masoud Toloue | 670,950 | 1,170,000 | 2,729,998 | 674,172 | 5,250,745 |
| 15 | Cytek Biosciences, Inc. | 2025 | Wenbin Jiang | 620,000 | 2,000,000 | 2,000,000 | 485,211 | 5,120,061 |
| 16 | Pacific Biosciences of California, Inc. | 2025 | Christian Henry | 748,250 | 1,151,013 | 1,696,278 | 714,305 | 4,309,846 |
| 17 | REGENXBIO Inc. | 2025 | Curran Simpson | 665,510 | 777,448 | 2,350,302 | 387,327 | 4,200,712 |
| 18 | Schrödinger, Inc. | 2025 | Ramy Farid | 730,000 | 796,500 | 1,966,876 | 570,860 | 4,079,043 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Twist Bioscience Corp | 129.6% | PSU 50 · RSU 50 | No | not disclosed |
| 10x Genomics, Inc. | 93% | PSU 60 · RSU 40 | Yes — 3-year Relative TSR | Alpine Rewards LLC |
| Azenta, Inc. | 107.4% | PSU 50 · RSU 50 | Yes — Relative Total Shareholder Return (rTSR) | Pearl Meyer |
| BioLife Solutions, Inc. | 88% | RSU 50 · PSU 50 | Yes — Total Shareholder Return (TSR) | Frederic W. Cook & Co, Inc. |
| CareDx, Inc. | 122% | RSU 70 · PSU 30 | No | Alpine Rewards |
| Cytek Biosciences, Inc. | 78.4% | RSU 50 · Options 50 | not disclosed | Meridian Compensation Partners, LLC |
| Guardant Health, Inc. | 140% | PSU 50 · RSU 50 | No | Aon |
| Insmed Incorporated | 175% | Options 75 · RSU 25 | No | Willis Towers Watson (WTW) |
| Maravai LifeSciences Holdings, Inc. | not disclosed | not disclosed | No | Meridian Compensation Partners, LLC |
| Natera, Inc. | 131.1% | PSU 50 · RSU 50 | No | Aon |
| NeoGenomics, Inc. | 60% | RSU 50 · Options 50 | not disclosed | WTW |
| NovoCure Limited | 100% | PSU 50 · RSU 25 · Options 25 | No | Frederic W. Cook & Co., Inc. |
| Pacific Biosciences of California, Inc. | 95% | not disclosed | not disclosed | Aon Human Capital Solutions |
| Quanterix Corporation | 95% | Options 70 · RSU 30 | not disclosed | PayGov |
| REGENXBIO Inc. | 97% | Options 75 · RSU 25 | not disclosed | Willis Towers Watson |
| Schrödinger, Inc. | 92% | not disclosed | No | Aon |
| Ultragenyx Pharmaceutical Inc. | 44% | PSU 60 · RSU 20 · Options 20 | Yes — Relative TSR | Aon's Human Capital Solutions Practice |
| Veracyte, Inc. | 118% | PSU 50 · RSU 50 | No | Aon |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Emily Leproust | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Summary Compensation Table” · page 43. As printed: 13,781,570. Filing ↗machine: t34 · r2 · c15 · span 1510951–1510961 |
| 2 | Section 01, Patrick Finn | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Summary Compensation Table” · page 43. As printed: 8,022,942. Filing ↗machine: t34 · r7 · c15 · span 1541554–1541563 |
| 3 | Section 01, Adam Laponis | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Summary Compensation Table” · page 43. As printed: 4,216,117. Filing ↗machine: t34 · r5 · c15 · span 1528424–1528433 |
| 4 | Section 01, Dennis Cho | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Summary Compensation Table” · page 43. As printed: 3,621,076. Filing ↗machine: t34 · r13 · c15 · span 1577450–1577459 |
| 5 | Section 01, Paula Green | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Summary Compensation Table” · page 43. As printed: 3,348,859. Filing ↗machine: t34 · r10 · c15 · span 1559702–1559711 |
| 6 | Section 03, Adam Laponis PSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r3 · c4 · span 1274514–1274520 |
| 7 | Section 03, Adam Laponis RSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t35 · r8 · c12 · span 1657185–1657191 |
| 8 | Section 03, Patrick Finn RSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t35 · r11 · c12 · span 1670606–1670612 |
| 9 | Section 03, Emily Leproust RSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r2 · c6 · span 1272578–1272584 |
| 10 | Section 03, Emily Leproust RSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t35 · r5 · c12 · span 1644952–1644958 |
| 11 | Section 03, Paula Green RSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r5 · c6 · span 1280221–1280227 |
| 12 | Section 03, Patrick Finn RSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r4 · c6 · span 1277675–1277681 |
| 13 | Section 03, Emily Leproust PSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r2 · c4 · span 1271914–1271920 |
| 14 | Section 03, Paula Green PSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r5 · c4 · span 1279616–1279622 |
| 15 | Section 03, Dennis Cho RSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t35 · r17 · c12 · span 1696272–1696278 |
| 16 | Section 03, Adam Laponis RSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r3 · c6 · span 1275117–1275123 |
| 17 | Section 03, Dennis Cho PSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r6 · c4 · span 1282164–1282170 |
| 18 | Section 03, Patrick Finn PSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r4 · c4 · span 1277069–1277075 |
| 19 | Section 03, Paula Green RSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t35 · r14 · c12 · span 1682850–1682856 |
| 20 | Section 03, Dennis Cho RSU | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Grants of Plan-Based Awards in Fiscal Year” · grants of plan-based awards table. Filing ↗machine: t29 · r6 · c6 · span 1282770–1282776 |
| 21 | Section 07, pay ratio | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “CEO Pay Ratio”. As printed: 73.2 : 1. Filing ↗machine: t42 · r1 · c1 · span 2421139–2421146 |
| 22 | Section 08, Trynka Shineman Blake | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Director Compensation”. As printed: 403,995. Filing ↗machine: t11 · r8 · c12 · span 427365–427372 |
| 23 | Section 08, Robert Chess | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Director Compensation”. As printed: 337,468. Filing ↗machine: t11 · r3 · c12 · span 402132–402139 |
| 24 | Section 08, Jan Johannessen | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Director Compensation”. As printed: 313,718. Filing ↗machine: t11 · r5 · c12 · span 412302–412309 |
| 25 | Section 08, Nelson C. Chan | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Director Compensation”. As printed: 312,468. Filing ↗machine: t11 · r2 · c12 · span 397046–397053 |
| 26 | Section 08, Melissa A. Starovasnik | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Director Compensation”. As printed: 304,968. Filing ↗machine: t11 · r9 · c12 · span 432475–432482 |
| 27 | Section 08, Robert Ragusa | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Director Compensation”. As printed: 304,968. Filing ↗machine: t11 · r7 · c12 · span 422258–422265 |
| 28 | Section 08, Keith Crandell | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Director Compensation”. As printed: 299,968. Filing ↗machine: t11 · r4 · c12 · span 407213–407220 |
| 29 | Section 08, Xiaoying Mai | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Director Compensation”. As printed: 181,952. Filing ↗machine: t11 · r6 · c12 · span 417164–417171 |
| 30 | Section 08, Emily M. Leproust | DEF 14A | 2026-01-06 | 0001581280-26-000006 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 31 | Section 02, Adam Laponis 2026-01-09 | Form 4 | 2026-01-13 | 0001214659-26-000423 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Adam Laponis 2026-01-13 | Form 4 | 2026-01-15 | 0001214659-26-000509 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Patrick Finn 2026-01-13 | Form 4 | 2026-01-15 | 0001214659-26-000508 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Patrick Finn 2026-01-13 | Form 4 | 2026-01-15 | 0001214659-26-000508 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Patrick Finn 2026-01-13 | Form 4 | 2026-01-15 | 0001214659-26-000508 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Patrick Finn 2026-01-23 | Form 4 | 2026-01-27 | 0001214659-26-000873 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Emily M. Leproust 2026-02-03 | Form 4 | 2026-02-05 | 0001214659-26-001240 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Dennis Cho 2026-02-03 | Form 4 | 2026-02-05 | 0001214659-26-001236 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Robert F. Werner 2026-02-03 | Form 4 | 2026-02-05 | 0001214659-26-001239 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Patrick Finn 2026-02-03 | Form 4 | 2026-02-05 | 0001214659-26-001237 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Robert F. Werner 2026-02-03 | Form 4 | 2026-02-05 | 0001214659-26-001239 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Paula Green 2026-02-03 | Form 4 | 2026-02-05 | 0001214659-26-001238 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Jan Johannessen 2026-02-05 | Form 4 | 2026-02-09 | 0001214659-26-001339 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Keith Crandell 2026-02-05 | Form 4 | 2026-02-09 | 0001214659-26-001352 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Jan Johannessen 2026-02-05 | Form 4 | 2026-02-09 | 0001214659-26-001339 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Nelson C. Chan 2026-02-05 | Form 4 | 2026-02-09 | 0001214659-26-001341 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Trynka Shineman Blake 2026-02-05 | Form 4 | 2026-02-09 | 0001214659-26-001340 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Robert Chess 2026-02-05 | Form 4 | 2026-02-09 | 0001214659-26-001342 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Robert Ragusa 2026-02-05 | Form 4 | 2026-02-09 | 0001214659-26-001343 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Melissa A. Starovasnik 2026-02-05 | Form 4 | 2026-02-09 | 0001214659-26-001344 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Robert F. Werner 2026-02-09 | Form 4 | 2026-02-11 | 0001214659-26-001492 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Dennis Cho 2026-02-11 | Form 4 | 2026-02-13 | 0001214659-26-001724 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Patrick Finn 2026-02-12 | Form 4 | 2026-02-17 | 0001214659-26-002041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Patrick Finn 2026-02-12 | Form 4 | 2026-02-17 | 0001214659-26-002041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Patrick Finn 2026-02-12 | Form 4 | 2026-02-17 | 0001214659-26-002041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Patrick Finn 2026-02-12 | Form 4 | 2026-02-17 | 0001214659-26-002041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Patrick Finn 2026-02-12 | Form 4 | 2026-02-17 | 0001214659-26-002041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Patrick Finn 2026-02-12 | Form 4 | 2026-02-17 | 0001214659-26-002041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Adam Laponis 2026-02-12 | Form 4 | 2026-02-13 | 0001214659-26-001737 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Patrick Finn 2026-02-12 | Form 4 | 2026-02-17 | 0001214659-26-002041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Patrick Finn 2026-02-12 | Form 4 | 2026-02-17 | 0001214659-26-002041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Patrick Finn 2026-02-12 | Form 4 | 2026-02-17 | 0001214659-26-002041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Patrick Finn 2026-02-12 | Form 4 | 2026-02-17 | 0001214659-26-002041 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Robert Chess 2026-02-13 | Form 4 | 2026-02-18 | 0001214659-26-002125 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Patrick Finn 2026-02-17 | Form 4 | 2026-02-19 | 0001214659-26-002179 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Patrick Finn 2026-02-17 | Form 4 | 2026-02-19 | 0001214659-26-002179 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Patrick Finn 2026-02-17 | Form 4 | 2026-02-19 | 0001214659-26-002179 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Patrick Finn 2026-02-17 | Form 4 | 2026-02-19 | 0001214659-26-002179 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Patrick Finn 2026-02-17 | Form 4 | 2026-02-19 | 0001214659-26-002179 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Patrick Finn 2026-02-17 | Form 4 | 2026-02-19 | 0001214659-26-002179 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Patrick Finn 2026-02-17 | Form 4 | 2026-02-19 | 0001214659-26-002179 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Patrick Finn 2026-02-17 | Form 4 | 2026-02-19 | 0001214659-26-002179 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Paula Green 2026-02-17 | Form 4 | 2026-02-19 | 0001214659-26-002180 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Dennis Cho 2026-02-23 | Form 4 | 2026-02-25 | 0001214659-26-002446 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Paula Green 2026-02-23 | Form 4 | 2026-02-25 | 0001214659-26-002447 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, Robert F. Werner 2026-02-23 | Form 4 | 2026-02-25 | 0001214659-26-002443 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, Emily M. Leproust 2026-02-23 | Form 4 | 2026-02-25 | 0001214659-26-002441 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, Patrick Finn 2026-02-23 | Form 4 | 2026-02-25 | 0001214659-26-002445 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 02, Adam Laponis 2026-02-23 | Form 4 | 2026-02-25 | 0001214659-26-002442 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 80 | Section 02, Robert F. Werner 2026-03-06 | Form 4 | 2026-03-10 | 0001214659-26-003067 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 81 | Section 02, Paula Green 2026-03-06 | Form 4 | 2026-03-10 | 0001214659-26-003064 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 82 | Section 02, Dennis Cho 2026-03-06 | Form 4 | 2026-03-10 | 0001214659-26-003065 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 83 | Section 02, Emily M. Leproust 2026-03-06 | Form 4 | 2026-03-10 | 0001214659-26-003063 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 84 | Section 02, Robert Chess 2026-03-17 | Form 4 | 2026-03-19 | 0001214659-26-003483 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 85 | Section 02, Robert Chess 2026-03-17 | Form 4 | 2026-03-19 | 0001214659-26-003483 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 86 | Section 02, Robert Chess 2026-03-17 | Form 4 | 2026-03-19 | 0001214659-26-003483 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 87 | Section 02, Paula Green 2026-03-20 | Form 4 | 2026-03-24 | 0001214659-26-003722 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 88 | Section 02, Emily M. Leproust 2026-03-20 | Form 4 | 2026-03-24 | 0001214659-26-003721 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 89 | Section 02, Dennis Cho 2026-03-20 | Form 4 | 2026-03-24 | 0001214659-26-003723 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 90 | Section 02, Melissa A. Starovasnik 2026-04-01 | Form 4 | 2026-04-03 | 0001214659-26-004333 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 91 | Section 02, Adam Laponis 2026-04-09 | Form 4 | 2026-04-13 | 0001214659-26-004601 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 92 | Section 02, Adam Laponis 2026-04-14 | Form 4 | 2026-04-16 | 0001214659-26-004735 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 93 | Section 02, Adam Laponis 2026-04-17 | Form 4 | 2026-04-21 | 0001214659-26-004893 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 94 | Section 02, Emily M. Leproust 2026-04-21 | Form 4 | 2026-04-23 | 0001214659-26-005005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 95 | Section 02, Emily M. Leproust 2026-04-21 | Form 4 | 2026-04-23 | 0001214659-26-005005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 96 | Section 02, Emily M. Leproust 2026-04-21 | Form 4 | 2026-04-23 | 0001214659-26-005005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 97 | Section 02, Emily M. Leproust 2026-04-21 | Form 4 | 2026-04-23 | 0001214659-26-005005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 98 | Section 02, Emily M. Leproust 2026-04-21 | Form 4 | 2026-04-23 | 0001214659-26-005005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 99 | Section 02, Emily M. Leproust 2026-04-21 | Form 4 | 2026-04-23 | 0001214659-26-005005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 100 | Section 02, Emily M. Leproust 2026-04-21 | Form 4 | 2026-04-23 | 0001214659-26-005005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 101 | Section 02, Patrick Finn 2026-04-23 | Form 4 | 2026-04-27 | 0001214659-26-005124 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 102 | Section 02, Melissa A. Starovasnik 2026-04-27 | Form 4 | 2026-04-29 | 0001214659-26-005250 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 103 | Section 02, Paula Green 2026-05-04 | Form 4 | 2026-05-06 | 0001214659-26-005673 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 104 | Section 02, Emily M. Leproust 2026-05-04 | Form 4 | 2026-05-06 | 0001214659-26-005675 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 105 | Section 02, Dennis Cho 2026-05-04 | Form 4 | 2026-05-06 | 0001214659-26-005676 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 106 | Section 02, Robert F. Werner 2026-05-04 | Form 4 | 2026-05-06 | 0001214659-26-005672 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 107 | Section 02, Patrick Finn 2026-05-04 | Form 4 | 2026-05-06 | 0001214659-26-005674 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 108 | Section 02, Robert F. Werner 2026-05-08 | Form 4 | 2026-05-12 | 0001214659-26-005987 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 109 | Section 02, Jan Johannessen 2026-05-12 | Form 4 | 2026-05-14 | 0001214659-26-006205 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 110 | Section 02, Jan Johannessen 2026-05-12 | Form 4 | 2026-05-14 | 0001214659-26-006205 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 111 | Section 02, Jan Johannessen 2026-05-12 | Form 4 | 2026-05-14 | 0001214659-26-006205 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 112 | Section 02, Dennis Cho 2026-05-21 | Form 4 | 2026-05-26 | 0001214659-26-006709 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 113 | Section 02, Paula Green 2026-05-21 | Form 4 | 2026-05-26 | 0001214659-26-006711 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 114 | Section 02, Patrick Finn 2026-05-21 | Form 4 | 2026-05-26 | 0001214659-26-006710 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 115 | Section 02, Adam Laponis 2026-05-21 | Form 4 | 2026-05-26 | 0001214659-26-006712 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 116 | Section 02, Emily M. Leproust 2026-05-21 | Form 4 | 2026-05-26 | 0001214659-26-006713 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 117 | Section 02, Robert F. Werner 2026-05-21 | Form 4 | 2026-05-26 | 0001214659-26-006714 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 118 | Section 02, Emily M. Leproust 2026-05-26 | Form 4 | 2026-05-28 | 0001214659-26-006835 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 119 | Section 02, Emily M. Leproust 2026-05-26 | Form 4 | 2026-05-28 | 0001214659-26-006835 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 120 | Section 02, Robert F. Werner 2026-05-26 | Form 4 | 2026-05-28 | 0001214659-26-006834 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 121 | Section 02, Emily M. Leproust 2026-05-26 | Form 4 | 2026-05-28 | 0001214659-26-006835 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 122 | Section 02, Melissa A. Starovasnik 2026-05-26 | Form 4 | 2026-05-28 | 0001214659-26-006833 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 123 | Section 02, Emily M. Leproust 2026-05-26 | Form 4 | 2026-05-28 | 0001214659-26-006835 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 124 | Section 02, Emily M. Leproust 2026-05-26 | Form 4 | 2026-05-28 | 0001214659-26-006835 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 125 | Section 02, Emily M. Leproust 2026-05-26 | Form 4 | 2026-05-28 | 0001214659-26-006835 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 126 | Section 02, Emily M. Leproust 2026-05-26 | Form 4 | 2026-05-28 | 0001214659-26-006835 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 127 | Section 02, Emily M. Leproust 2026-05-28 | Form 4 | 2026-06-01 | 0001214659-26-006967 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 128 | Section 02, Emily M. Leproust 2026-05-28 | Form 4 | 2026-06-01 | 0001214659-26-006967 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 129 | Section 02, Melissa A. Starovasnik 2026-05-28 | Form 4 | 2026-06-01 | 0001214659-26-006966 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 130 | Section 02, Emily M. Leproust 2026-05-28 | Form 4 | 2026-06-01 | 0001214659-26-006967 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 131 | Section 02, Emily M. Leproust 2026-05-28 | Form 4 | 2026-06-01 | 0001214659-26-006967 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 132 | Section 02, Emily M. Leproust 2026-05-28 | Form 4 | 2026-06-01 | 0001214659-26-006967 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 133 | Section 02, Emily M. Leproust 2026-05-28 | Form 4 | 2026-06-01 | 0001214659-26-006967 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 134 | Section 02, Dennis Cho 2026-05-29 | Form 4 | 2026-06-02 | 0001214659-26-007030 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 135 | Section 02, Adam Laponis 2026-05-29 | Form 4 | 2026-06-02 | 0001214659-26-007029 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 136 | Section 02, Robert F. Werner 2026-06-08 | Form 4 | 2026-06-10 | 0001214659-26-007315 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 137 | Section 02, Emily M. Leproust 2026-06-08 | Form 4 | 2026-06-10 | 0001214659-26-007316 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 138 | Section 02, Dennis Cho 2026-06-08 | Form 4 | 2026-06-10 | 0001214659-26-007318 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 139 | Section 02, Robert F. Werner 2026-06-08 | Form 4 | 2026-06-10 | 0001214659-26-007315 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 140 | Section 02, Robert F. Werner 2026-06-08 | Form 4 | 2026-06-10 | 0001214659-26-007315 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 141 | Section 02, Paula Green 2026-06-08 | Form 4 | 2026-06-10 | 0001214659-26-007317 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 142 | Section 02, Paula Green 2026-06-15 | Form 4 | 2026-06-17 | 0001214659-26-007525 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 143 | Section 02, Paula Green 2026-06-15 | Form 4 | 2026-06-17 | 0001214659-26-007525 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 144 | Section 02, Paula Green 2026-06-15 | Form 4 | 2026-06-17 | 0001214659-26-007525 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 145 | Section 02, Paula Green 2026-06-15 | Form 4 | 2026-06-17 | 0001214659-26-007525 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 146 | Section 02, Emily M. Leproust 2026-06-22 | Form 4 | 2026-06-24 | 0001214659-26-007692 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 147 | Section 02, Paula Green 2026-06-22 | Form 4 | 2026-06-24 | 0001214659-26-007694 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 148 | Section 02, Dennis Cho 2026-06-22 | Form 4 | 2026-06-24 | 0001214659-26-007693 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 149 | Section 02, Dennis Cho 2026-06-24 | Form 4 | 2026-06-26 | 0001214659-26-007793 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 150 | Section 02, Emily M. Leproust 2026-06-25 | Form 4 | 2026-06-26 | 0001214659-26-007800 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 151 | Section 02, Adam Laponis 2026-07-09 | Form 4 | 2026-07-13 | 0001214659-26-008480 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 152 | Section 02, Patrick Finn 2026-07-23 | Form 4 | 2026-07-27 | 0001214659-26-009065 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 153 | Section 06, 2026 vote | Form 8-K | 2026-02-06 | 0001581280-26-000022 | Item 5.07 · say-on-pay result. As reported: 76.44% (votes for as printed: 38,430,673). Filing ↗ |
| 154 | Section 06, 2025 vote | Form 8-K | 2025-02-11 | 0001104659-25-011543 | Item 5.07 · say-on-pay result. As reported: 97.63% (votes for as printed: 49,586,486). Filing ↗ |
| 155 | Section 06, 2024 vote | Form 8-K | 2024-02-07 | 0001104659-24-011607 | Item 5.07 · say-on-pay result. As reported: 93.7% (votes for as printed: 43,215,571). Filing ↗ |
| 156 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 157 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 158 | Section 09b board cost (computed) | Computed | — | computed | Cash 476,143 + equity 1,834,803 + all other 148,559 = 2,459,505, summed across the director compensation table rows.machine: formula: Σ = 2,459,505 |
| 159 | Natera, Inc., Section 10b CEO total | DEF 14A | 2026-04-23 | 0001104659-26-047770 | CEO total compensation as printed in Natera, Inc.'s own proxy. As printed: 14,957,319. Filing ↗machine: t190 · r5 · c14 · span 1269868–1269878 |
| 160 | Insmed Incorporated, Section 10b CEO total | DEF 14A | 2026-04-01 | 0001104506-26-000022 | CEO total compensation as printed in Insmed Incorporated's own proxy. As printed: 14,467,393. Filing ↗machine: r4 · c51 · span 912553–912563 |
| 161 | Twist Bioscience Corp (subject), Section 10b CEO total | DEF 14A | 2026-01-06 | 0001581280-26-000006 | CEO total compensation as printed in Twist Bioscience Corp's own proxy. As printed: 13,781,570. Filing ↗machine: t34 · r2 · c15 · span 1510951–1510961 |
| 162 | NovoCure Limited, Section 10b CEO total | DEF 14A | 2026-04-20 | 0001645113-26-000033 | CEO total compensation as printed in NovoCure Limited's own proxy. As printed: 13,198,354. Filing ↗machine: r6 · c48 · span 880842–880852 |
| 163 | Ultragenyx Pharmaceutical Inc., Section 10b CEO total | DEF 14A | 2026-03-27 | 0001308179-26-000174 | CEO total compensation as printed in Ultragenyx Pharmaceutical Inc.'s own proxy. As printed: 11,405,535. Filing ↗machine: span 668997–669007 |
| 164 | Azenta, Inc., Section 10b CEO total | DEF 14A | 2025-12-18 | 0001140361-25-046064 | CEO total compensation as printed in Azenta, Inc.'s own proxy. As printed: 10,371,414. Filing ↗machine: r2 · c22 · span 1247118–1247129 |
| 165 | Maravai LifeSciences Holdings, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001823239-26-000014 | CEO total compensation as printed in Maravai LifeSciences Holdings, Inc.'s own proxy. As printed: 10,129,708. Filing ↗machine: t21 · r3 · c20 · span 502645–502655 |
| 166 | NeoGenomics, Inc., Section 10b CEO total | DEF 14A | 2026-04-06 | 0001077183-26-000014 | CEO total compensation as printed in NeoGenomics, Inc.'s own proxy. As printed: 9,127,092. Filing ↗machine: r2 · c45 · span 869460–869469 |
| 167 | Guardant Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001193125-26-187403 | CEO total compensation as printed in Guardant Health, Inc.'s own proxy. As printed: 8,661,227. Filing ↗machine: r7 · c31 · span 773149–773158 |
| 168 | Veracyte, Inc., Section 10b CEO total | DEF 14A | 2026-04-22 | 0001384101-26-000021 | CEO total compensation as printed in Veracyte, Inc.'s own proxy. As printed: 7,421,877. Filing ↗machine: r4 · c27 · span 855413–855422 |
| 169 | CareDx, Inc., Section 10b CEO total | DEF 14A | 2026-04-27 | 0001217234-26-000028 | CEO total compensation as printed in CareDx, Inc.'s own proxy. As printed: 7,179,699. Filing ↗machine: t113 · r3 · c9 · span 1893652–1893661 |
| 170 | BioLife Solutions, Inc., Section 10b CEO total | DEF 14A | 2025-07-08 | 0000834365-25-000007 | CEO total compensation as printed in BioLife Solutions, Inc.'s own proxy. As printed: 7,046,205. Filing ↗machine: t19 · r3 · c19 · span 344908–344917 |
| 171 | 10x Genomics, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001628280-26-027201 | CEO total compensation as printed in 10x Genomics, Inc.'s own proxy. As printed: 6,329,244. Filing ↗machine: r3 · c48 · span 583283–583292 |
| 172 | Quanterix Corporation, Section 10b CEO total | DEF 14A | 2026-04-24 | 0001104659-26-048166 | CEO total compensation as printed in Quanterix Corporation's own proxy. As printed: 5,250,745. Filing ↗machine: t18 · r1 · c47 · span 503076–503085 |
| 173 | Cytek Biosciences, Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001140361-26-017479 | CEO total compensation as printed in Cytek Biosciences, Inc.'s own proxy. As printed: 5,120,061. Filing ↗machine: r2 · c21 · span 561243–561252 |
| 174 | Pacific Biosciences of California, Inc., Section 10b CEO total | DEF 14A | 2026-04-23 | 0001299130-26-000064 | CEO total compensation as printed in Pacific Biosciences of California, Inc.'s own proxy. As printed: 4,309,846. Filing ↗machine: r2 · c48 · span 876974–876983 |
| 175 | REGENXBIO Inc., Section 10b CEO total | DEF 14A | 2026-04-14 | 0001193125-26-155058 | CEO total compensation as printed in REGENXBIO Inc.'s own proxy. As printed: 4,200,712. Filing ↗machine: r2 · c16 · span 436444–436453 |
| 176 | Schrödinger, Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001490978-26-000026 | CEO total compensation as printed in Schrödinger, Inc.'s own proxy. As printed: 4,079,043. Filing ↗machine: span 722763–722772 |
| 177 | Section 10a, Quanterix Corporation reciprocity | DEF 14A | — | 0001104659-26-048166 | Quanterix Corporation names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 178 | Section 10a, BioLife Solutions, Inc. reciprocity | DEF 14A | — | 0000834365-25-000007 | BioLife Solutions, Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗ |
| 179 | Section 10a, Veracyte, Inc. reciprocity | DEF 14A | — | 0001384101-26-000021 | Veracyte, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 180 | Section 10a, Schrödinger, Inc. reciprocity | DEF 14A | — | 0001490978-26-000026 | Schrödinger, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 181 | Section 10a, Ultragenyx Pharmaceutical Inc. reciprocity | DEF 14A | — | 0001308179-26-000174 | Ultragenyx Pharmaceutical Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗ |
| 182 | Section 10a, Pacific Biosciences of California, Inc. reciprocity | DEF 14A | — | 0001299130-26-000064 | Pacific Biosciences of California, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 183 | Section 10a, Cytek Biosciences, Inc. reciprocity | DEF 14A | — | 0001140361-26-017479 | Cytek Biosciences, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 184 | Section 10a, NovoCure Limited reciprocity | DEF 14A | — | 0001645113-26-000033 | NovoCure Limited's most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗ |
| 185 | Section 10a, 10x Genomics, Inc. reciprocity | DEF 14A | — | 0001628280-26-027201 | 10x Genomics, Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗ |
| 186 | Section 10a, Insmed Incorporated reciprocity | DEF 14A | — | 0001104506-26-000022 | Insmed Incorporated's most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗ |
| 187 | Section 10a, Azenta, Inc. reciprocity | DEF 14A | — | 0001140361-25-046064 | Azenta, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 188 | Section 10a, Maravai LifeSciences Holdings, Inc. reciprocity | DEF 14A | — | 0001823239-26-000014 | Maravai LifeSciences Holdings, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 189 | Section 10a, Natera, Inc. reciprocity | DEF 14A | — | 0001104659-26-047770 | Natera, Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗ |
| 190 | Section 10a, CareDx, Inc. reciprocity | DEF 14A | — | 0001217234-26-000028 | CareDx, Inc. names Twist Bioscience Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 191 | Section 10a, NeoGenomics, Inc. reciprocity | DEF 14A | — | 0001077183-26-000014 | NeoGenomics, Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗ |
| 192 | Section 10a, Guardant Health, Inc. reciprocity | DEF 14A | — | 0001193125-26-187403 | Guardant Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Twist Bioscience Corp. Filing ↗ |